A new trial suggests a combination vaccine may offer equal or better protection against both flu and covid-19 compared to ...

We recently published a list of Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential. In this ...

Moderna’s stock has experienced a significant decline of 12.90% over the past week, reflecting investor concerns about the company’s recent financial performance and future prospects. The ...

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

ANSWER: The problem isn’t that your immune system isn’t working; it’s working a little too well for your comfort but very well for your safety. The common side effect of muscle and joint aches with ...

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

The trial found that antibody levels were higher for COVID and all but one flu strain in those who got the combo.

Moderna has tested its first flu and COVID combination vaccine shot. Dr. Bill Hartman from UW Health joined FOX6 to talk ...

(Gray News) - A combination shot for flu and COVID-19 using messenger RNA-generated antibodies in a study, but U.S. government regulators want to see data on whether the new vaccine protects people ...

Moderna’s new combination vaccine for seasonal influenza and COVID-19 has outperformed current standard vaccines in a large phase 3 clinical trial, showing stronger immune responses to both viruses in ...

Moderna also hopes that combining the shots will help improve vaccine rates. Poland, however, is not sure people will like ...

Senior leaders at the FDA began pushing Moderna and Pfizer to file for full, formal approval of their COVID vaccines for ...